Diploma PLC (LON:DPLM) Insider David S. Lowden Purchases 750 Shares

Diploma PLC (LON:DPLM) insider David S. Lowden acquired 750 shares of the company’s stock in a transaction on Friday, March 21st. The stock was purchased at an average cost of GBX 3,928 ($50.76) per share, for a total transaction of £29,460 ($38,066.93).

Diploma Stock Up 1.2 %

Diploma stock opened at GBX 3,982 ($51.45) on Tuesday. The stock’s 50 day moving average price is GBX 4,388.20 and its 200 day moving average price is GBX 4,381.82. Diploma PLC has a 1-year low of GBX 3,372 ($43.57) and a 1-year high of GBX 4,808 ($62.13). The company has a market cap of £5.31 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80.

Diploma Increases Dividend

The business also recently announced a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were given a dividend of GBX 42 ($0.54) per share. This is a positive change from Diploma’s previous dividend of $17.30. This represents a dividend yield of 0.93%. The ex-dividend date was Thursday, January 16th. Diploma’s payout ratio is presently 65.52%.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. lifted their target price on shares of Diploma from GBX 4,370 ($56.47) to GBX 4,420 ($57.11) and gave the company a “neutral” rating in a report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Diploma currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($59.02).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.